Page last updated: 2024-10-30

lansoprazole and Gynecomastia

lansoprazole has been researched along with Gynecomastia in 2 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Gynecomastia: Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Comas, A1
Salgueiro, E1
Hidalgo, A1
Cuervo Martín, JR1
García Ortega, P1
Sánchez Sánchez, A1
Carvajal García-Pando, A1

Other Studies

2 other studies available for lansoprazole and Gynecomastia

ArticleYear
[Lansoprazole-induced gynecomastia].
    Medicina clinica, 2000, Mar-18, Volume: 114, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Gynecomastia; H

2000
[Gynecomastia associated with the simultaneous use of cisapride and lansoprazole].
    Medicina clinica, 2001, Mar-24, Volume: 116, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Cisapride; Drug Combinations; Gast

2001